| |
Latex and Rubber Closures Information
The following products distributed by American Regent, Inc., have closures that DO NOT CONTAIN latex or natural rubber:
Acetylcysteine Solution, USP, 10%, 4 mL Vial
Acetylcysteine Solution, USP, 10%, 10 mL Vial
Acetylcysteine Solution, USP, 20%, 4 mL Vial
Acetylcysteine Solution, USP, 20%, 10 mL Vial
Acetylcysteine Solution, USP, 20%, 30 mL Vial
Aminophylline Injection, USP, 250 mg/10 mL, 10 mL Single Dose Vial
Aminophylline Injection, USP, 500 mg/20 mL, 20 mL Single Dose Vial
Ammonium Molybdate Injection, USP, 25 mcg/mL, 10 mL Single Dose Vial
Ascorbic Acid Injection, USP, 500 mg/mL, 50 mL Sterile Dispensing Vial
Caffeine Citrate Injection, USP, 60 mg/3 mL, 3 mL Single Dose Vial
Ceftriaxone for Injection, USP, 250 mg, Single Dose Vial
Ceftriaxone for Injection, USP, 500 mg, Single Dose Vial
Ceftriaxone for Injection, USP, 1 gram, Single Dose Vial
Ceftriaxone for Injection, USP, 2 grams, Single Dose Vial
Cyanocobalamin Injection, USP, 1000 mcg/mL, 1 mL Vial
Cyanocobalamin Injection, USP, 1000 mcg/mL, 10 mL Multiple Dose Vial
Droperidol Injection, USP, 2.5 mg/mL, 2 mL Single Dose Vial
Furosemide Injection, USP, 20 mg/2 mL, 2 mL Single Dose Vial
Furosemide Injection, USP, 40 mg/4 mL, 4 mL Single Dose Vial
Furosemide Injection, USP, 100 mg/10 mL, 10 mL Single Dose Vial
Glycopyrrolate Injection, USP, 0.2 mg/mL, 1 mL Single Dose Vial
Glycopyrrolate Injection, USP, 0.2 mg/mL, 2 mL Single Dose Vial
Glycopyrrolate Injection, USP, 0.2 mg/mL, 5 mL Multiple Dose Vial
Glycopyrrolate Injection, USP, 0.2 mg/mL, 20 mL Multiple Dose Vial
Hydralazine HCl Injection, USP, 20 mg/mL, 1 mL Single Dose Vial
Ketorolac Tromethamine, USP, 15mg/mL, 1 mL Single Dose Vial
Ketorolac Tromethamine, USP, 30mg/mL, 1 mL Single Dose Vial
Ketorolac Tromethamine, USP, 60mg/mL, 2 mL Single Dose Vial
Levocarnitine Injection, USP, 1 g/5 mL, 5 mL Single Dose Vial
Manganese Sulfate Injection, USP, Manganese 1 mg/10 mL (0.1 mg/mL)
Mannitol Injection, USP, 25%, 50 mL Single Dose Vial
Multitrace™-4 (Trace Elements Injection 4, USP), 10 mL Multiple Dose Vial
Multitrace™-4 Concentrate (Trace Elements Injection 4, USP), 1 mL Single Dose Vial
Multitrace™-4 Concentrate (Trace Elements Injection 4, USP), 10 mL Multiple Dose Vial
Multitrace™-4 Neonatal (Trace Elements Injection 4, USP), 2 mL Single Dose Vial
Multitrace™-4 Pediatric (Trace Elements Injection 4, USP), 3 mL Single Dose Vial
Multitrace™-5 (Trace Elements Injection 5, USP), 10 mL Multiple Dose Vial
Multitrace™-5 Concentrate (Trace Elements Injection 5, USP), 1 mL Multiple Dose Vial
Multitrace™-5 Concentrate (Trace Elements Injection 5, USP), 10 mL Multiple Dose Vial
Neostigmine Methylsulfate Injection, USP, 0.5 mg/mL, 10 mL Multiple Dose Vial
Nitroglycerin Injection, USP, 50 mg/10 mL, 10 mL Single Dose Vial
Papaverine HCl Injection, USP, 30 mg/mL, 2 mL Single Dose Vial
Papaverine HCl Injection, USP, 30 mg/mL, 10 mL Multiple Dose Vial
Phenylephrine HCl Injection, USP, 10 mg/mL, 1 mL Single Dose Vial
Phenylephrine HCl Injection, USP, 10mg/mL, 5 mL Vial
Potassium Acetate Injection, USP, 4 mEq/mL, 50 mL Single Dose Vial
Potassium Phosphates Injection, USP 3 mM/mL, 5 mL Single Dose Vial
Potassium Phosphates Injection, USP 3 mM/mL, 15 mL Single Dose Vial
Potassium Phosphates Injection, USP 3 mM/mL, 50 mL Single Dose Vial
Sodium Bicarbonate Injection, USP, 7.5%, 50 mL Single Dose Vial
Sodium Bicarbonate Injection, USP, 8.4%, 50 mL Single Dose Vial
Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial
Sodium Phosphates Injection, USP, 3 mM/mL, 5 mL Single Dose Vial
Sodium Phosphates Injection, USP, 3 mM/mL, 50 mL Single Dose Vial
Sodium Thiosulfate Injection, USP, 10%, 10 mL Single Dose Vial
Sodium Thiosulfate Injection, USP, 25%, 50 mL Single Dose Vial
Trace Elements Injection 4, USP-Pediatric, 10 mL Multiple Dose Vial
Vasopressin Injection, USP, 20 units/mL, 1 mL Multiple Dose Vial
Vasopressin Injection, USP, 20 units/mL, 10 mL Multiple Dose Vial
Venofer® (iron sucrose injection, USP), 20 mg/mL, 5 mL Single Dose Vial
Venofer® (iron sucrose injection, USP), 20 mg/mL, 10 mL Single Dose Vial
American Regent, Inc. is in the process of converting the closures on all our vials to a latex-free formulation. Below is a list of products that have been converted, followed by the date that the first lot of that product was manufactured with the latex-free closure.
Please note that for any product listed below, all future lots will be manufactured with the latex-free closure. Due to older lots still in the distribution pipeline, it is necessary to refer to the expiration date of the product listed below. Any product with an expiration date the same or later than the one listed below will have the latex-free closure.
|
Product/Description
|
NDC # 0517
|
Conversion Date
|
Expiration Date
|
|
Aminocaproic Acid Inj., USP
5 g/20 mL, 20 mL MDV
|
9120-05
|
01/06/06
|
01/09
|
|
Atropine Sulfate Inj., USP
0.4 mg/mL, 1 mL SDV
|
0401-25
|
8/22/05
|
8/08
|
|
Atropine Sulfate Inj., USP
1 mg/mL, 1 mL SDV
|
1010-25
|
10/05/05
|
10/08
|
|
Bacteriostatic Sodium Chloride Inj., USP
0.9% 9 mg/mL, 30 mL MDV
|
0648-25
|
02/04/08
|
02/10
|
|
Caffeine & Sodium Benzoate Inj., USP
0.5 g/2 mL, (250mg/mL) 2 mL SDV
|
2502-10
|
02/08/08
|
02/10
|
|
Chromic Chloride Inj., USP
Chromium 40 mcg/10 mL, 10 mL SDV
|
6310-25
|
01/10/08
|
01/10
|
|
Dexamethasone Sodium Phosphate Inj., USP
4 mg/mL, 1 mL SDV
|
4901-25
|
9/28/05
|
09/08
|
|
Dexamethasone Sodium Phosphate Inj., USP
4 mg/mL, 5 mL MDV
|
4905-25
|
10/13/05
|
10/08
|
|
Dexamethasone Sodium Phosphate Inj., USP
4 mg/mL, 30 mL MDV
|
4930-25
|
10/06/05
|
10/08
|
|
Dopamine HCl Inj., USP
160 mg/mL, 5 mL SDV
|
1305-25
|
12/09/06
|
12/09
|
|
Dopamine HCl Inj., USP
40 mg/mL, 5 mL SDV
|
1805-25
|
9/15/05
|
09/08
|
|
Sodium Phosphates Inj., USP
3 mM/mL, 15 mL SDV
|
3415-25
|
9/06/05
|
09/08
|
|
Zinc Sulfate Inj., USP
Zinc 10 mg/10 mL (1 mg/mL), 10 mL SDV
|
6110-25
|
10/17/05
|
10/08
|
|
Zinc Sulfate Inj., USP (Concentrated)
Zinc 25 mg/5 mL (5 mg/mL), 5 mL SDV
|
8105-25
|
01/31/06
|
01/09
|
» Back to top
|
